HighIL1RAP protein expression on tumor cells is linked to poor survival in PDAC patients treated with chemotherapy, while this patient group has the longest survival when treated with nadunolimab in combination with chemotherapy.
2025-10-01 00.00.00 CEST Cantargia AB - InvestorNews Cantargia presents data at an AACRConference strengthening IL1RAP as a targetable hallmark in PDAC. High IL1RAP protein expression on tumor cells ...